WellCare Health "The company could also see competition from non-profit competitors in the upcoming RFP pipeline, which could lead to lower rates," Wedbush analysts wrote in a March 26 report. "An additional risk is the possibility of the Supreme Court overturning Medicaid expansion in the Affordable Care Act." Shares of WellCare Health hit a 52-week high of $72.27 on Friday. The stock's 52-week high of $33.29 on Oct. 4. WellCare Health's forward P/E is 13.94; the average for health care providers is 17.99. For comparison, both Coventry Health ( CVH) and Amerigroup ( AGP) have lower forward P/Es of 10.1 and 13.29 times. Nine of the 14 analysts who cover WellCare Health rated it hold; five analysts gave the stock a buy rating. TheStreet Ratings gives WellCare Health a B grade with a buy rating and a $85.29 price target. The stock has risen 37.37% year to date.